Showing results (321-330 of 1,811) with videos related to

Sort By:
Pageof 182
Transplantation and Cellular Therapy|January 26, 2024
Impact of Natural Killer Cell-Associated Factors on Acute Leukemia Outcomes after Haploidentical Hematopoietic Stem Cell Transplantation with αβ T Cell Depletion in a Pediatric CohortSvetlana Glushkova, Larisa Shelikhova, Kirill Voronin, et al.
Transplantation and Cellular Therapy|January 26, 2024
Upfront Umbilical Cord Blood Transplantation Versus Immunosuppressive Therapy for Pediatric Patients With Idiopathic Severe Aplastic AnemiaXuxu Zhao, Wenxiu Lv, Kaidi Song, et al.
Transplantation and Cellular Therapy|January 8, 2024
Disparities in Cytomegalovirus Infection Rates by Race and Ethnicity among Pediatric Allogeneic Hematopoietic Cell Transplantation Recipients at a Single CenterCraig L K Boge, Molly Hayes McDonough, Alexander M Newman, et al.
Transplantation and Cellular Therapy|January 6, 2024
The Phenotype of a Bone Marrow Transplant Nurse: Survival of the FittestChelsea S Goodin, Christopher E Dandoy, Brenda Mott, et al.
Transplantation and Cellular Therapy|December 22, 2023
Development of a Pipeline for Removing Allergy Labels in Patients Undergoing Hematopoietic Stem Cell TransplantationLauren E Merz, George X Huang, Geneva D Mehta, et al.
Transplantation and Cellular Therapy|December 16, 2023
Alemtuzumab, Dual Graft-versus-Host Disease Prophylaxis, and Lower CD3+ T Cell Doses Equalize Rates of Acute and Chronic Graft-versus-Host Disease in Pediatric Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation with Matched Unrelated Donor Peripheral Blood Stem Cells or Bone Marrow GraftsSu Han Lum, Beki James, Giorgio Ottaviano, et al.
Transplantation and Cellular Therapy|December 20, 2023
Simple Score of Albumin and CRP Predicts High-Grade Toxicity in Patients with Multiple Myeloma Receiving CAR-T TherapyOthman S Akhtar, Karnav Modi, Jongphil Kim, et al.
Transplantation and Cellular Therapy|December 11, 2023
Comparison of Allogeneic Transplant Outcomes Between Matched Sibling Donors and Alternative Donors in Patients Over 50 Years of Age with Acute Myeloid Leukemia: 8/8 Allele-Matched Unrelated Donors and Unrelated Cord Blood Provide Better Leukemia-Free Survival Compared with Matched Sibling Donors During Nonremission StatusTakaaki Konuma, Satoshi Yamasaki, Ken Ishiyama, et al.
Transplantation and Cellular Therapy|December 6, 2023
Genetic Findings of Potential Donor Origin following Hematopoietic Cell Transplantation: Recommendations on Donor Disclosure and Genetic Testing from the World Marrow Donor AssociationAngharad Pryce, Eefke Van Eerden, Meghann Cody, et al.
Transplantation and Cellular Therapy|November 24, 2023
Easix Score Correlates With Endothelial Dysfunction Biomarkers and Predicts Risk of Acute Graft-Versus-Host Disease After Allogeneic TransplantationAlexandra Pedraza, María Queralt Salas, Luis Gerardo Rodríguez-Lobato, et al.
Pageof 182